Home » Genizon BioSciences Acquires Assets From Global Genomics
Genizon BioSciences Acquires Assets From Global Genomics
Genizon BioSciences, a Montreal-based gene and drug target discovery company, announced it has acquired the majority of the assets and staff of Sweden-based Global Genomics AB. Through this transaction, Genizon has gained access to a novel sequencing technology, five related patents/patent applications and proprietary algorithms for data analysis.
Canada NewsWire Group (http://www.newswire.ca/en/releases/archive/May2005/11/c7396.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May